Inaktiver Wert

Omthera Pharmaceuticals Inc Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Omthera Pharmaceuticals Inc : FDA accepts new drug application for investigational compound Epanova for the treatment of severe hypertriglyceridaemia	20.09.13
Omthera Pharmaceuticals Inc : Omthera Stockholders Approve Acquisition by AstraZeneca	16.07.13
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces NDA Submission for Epanova(TM) for the Treatment of Patients with Very High Triglycerides	09.07.13
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period	27.06.13
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders	13.06.13

Sektor

	% 1. Jan.	Kap.
MERCK KGAA	+7,39 %	72,09 Mrd.
KYOWA KIRIN CO. LTD.	+15,93 %	9,05 Mrd.
YUHAN CORPORATION	+17,59 %	4,39 Mrd.
SK BIOPHARMACEUTICALS CO., LTD.	-22,81 %	4,4 Mrd.
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+25,93 %	3,94 Mrd.
INDIVIOR PLC	+4,64 %	2,1 Mrd.
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+9,09 %	1,97 Mrd.
BETTA PHARMACEUTICALS CO., LTD.	-36,86 %	1,87 Mrd.
VELOXIS PHARMACEUTICALS A/S	-0,50 %	1,64 Mrd.